The emergence of AR splice variants is proposed as a mechanism of treatment resistance: thus, AR-Vs have been implicated in the treatment failure of prostate cancer patients undergoing androgen deprivation therapy alone or in combination with radiotherapy [222]. Here, AR is linked to prostate carcinoma.